DAVID SIDRANSKY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID SIDRANSKY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID SIDRANSKY. DAVID SIDRANSKY is Director in CHAMPIONS ONCOLOGY, INC. ($CSBR) and Director in IMCLONE SYSTEMS INC ($IMCLE) and Director in Advaxis, Inc. ($ADXS) and Director in Orgenesis Inc. ($ORGS).
Latest Insider Trading Transactions of DAVID SIDRANSKY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADXS, CSBR, IMCLE, ORGS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2021 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Buy | P | 6.98 | 10 | 70 | 180 | 170 to 180 (+5.88 %) |
Jan 11 2021 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Buy | P | 5.96 | 70 | 417 | 170 | 100 to 170 (+70.00 %) |
Jan 11 2021 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Buy | P | 5.90 | 90 | 531 | 100 | 10 to 100 (+900.00 %) |
Jan 11 2021 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Buy | P | 5.42 | 10 | 54 | 10 | 0 to 10 |
Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 11.96 | 8,333 | 99,663 | 8,333 | |
Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | M | 5.46 | 16,667 | 91,002 | 0 | |
Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Payment of Exercise | F | 9.01 | 10,100 | 91,001 | 748,234 | 758.3 K to 748.2 K (-1.33 %) |
Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Buy | M | 5.46 | 16,667 | 91,002 | 758,334 | 741.7 K to 758.3 K (+2.25 %) |
May 05 2020 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
Mar 20 2020 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 2.99 | 12,500 | 37,375 | 12,500 | |
Jan 16 2020 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 2.99 | 12,500 | 37,375 | 12,500 | |
Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 5.43 | 8,333 | 45,248 | 8,333 | |
Oct 25 2019 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
Nov 07 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.54 | 30,000 | 16,200 | 30,000 | |
Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 12.73 | 8,333 | 106,079 | 8,333 | |
Oct 25 2018 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 5.99 | 29,200 | 174,908 | 29,200 | |
Oct 25 2018 | ORGS | Orgenesis Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 9.00 | 20,834 | 187,506 | 20,834 | |
Jun 27 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 15,000 | 0 | 110,355 | 95.4 K to 110.4 K (+15.73 %) |
Jun 14 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.71 | 5,000 | 8,550 | 95,355 | 90.4 K to 95.4 K (+5.53 %) |
Jun 13 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.84 | 6,802 | 12,516 | 90,355 | 83.6 K to 90.4 K (+8.14 %) |
Jun 13 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.85 | 3,198 | 5,916 | 83,553 | 80.4 K to 83.6 K (+3.98 %) |
Nov 06 2017 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
Nov 07 2016 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 7.71 | 30,000 | 231,300 | 30,000 | |
Nov 03 2016 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 1.59 | 16,667 | 26,501 | 16,667 | |
Aug 10 2016 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Sell | S | 14.85 | 11,404 | 169,349 | 80,355 | 91.8 K to 80.4 K (-12.43 %) |
Aug 10 2016 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Sell | S | 15.17 | 11,404 | 172,999 | 91,759 | 103.2 K to 91.8 K (-11.05 %) |
Nov 06 2015 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 12.81 | 50,000 | 640,500 | 50,000 | |
Nov 06 2015 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 2,744 | 0 | 103,163 | 100.4 K to 103.2 K (+2.73 %) |
Nov 04 2015 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 5.46 | 16,667 | 91,002 | 16,667 | |
Apr 01 2015 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 13.44 | 20,000 | 268,800 | 20,000 | |
Apr 01 2015 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 15,000 | 0 | 100,419 | 85.4 K to 100.4 K (+17.56 %) |
Jan 19 2006 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 34.80 | 6,250 | 217,500 | 25,000 | |
Jan 19 2006 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 34.80 | 6,250 | 217,500 | 18,750 | |
Jan 19 2006 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 34.80 | 6,250 | 217,500 | 12,500 | |
Jan 19 2006 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 34.80 | 6,250 | 217,500 | 6,250 | |
Jan 05 2005 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 46.12 | 30,000 | 1,383,600 | 30,000 | |
Jan 23 2004 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 43.66 | 28,434 | 1,241,428 | 28,434 | |
Jan 23 2004 | IMCLE | IMCLONE SYSTEMS IN ... | SIDRANSKY DAVID | Director | Option Exercise | A | 43.66 | 50,000 | 2,183,000 | 50,000 |
Page: 1